Page results
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
-
More people with dementia in the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of new funding to build a network of dementia trials sites across the country.
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
UCLH has treated the first brain cancer patient with immunotherapy prior to standard treatment as part of a pioneering trial.
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Tens of thousands of people in England who have hepatitis C could now get tested and treated thanks to a new mobile health unit arriving to coincide with World Hepatitis Day on 28 July.
-
Information about the new government support available to help people pay their energy bills.
-
The haematology and critical care services in our flagship University College Hospital Grafton Way Building are now open.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
File results
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0578 - Spinal Muscular Atrophy (SMA) patients
-
FOI/2023/0579 - Procurement for specialist seating for patients
-
FOI/2023/0581 - Treatment of Haemophilia